Mark R. Davis

10.8k citations

119 papers · 4.8k indexed · 2 hit papers · h-index 32

Impact in

Cardiology and Cardiovascular Medicine top 1%
- Blood Pressure and Hypertension Studies
- Cardiomyopathy and Myosin Studies
- Heart Rate Variability and Autonomic Control
Genetics top 2%
- Neurogenetic and Muscular Disorders Research
- Genetics and Neurodevelopmental Disorders

Papers in

Genetics 23
- Neurogenetic and Muscular Disorders Research 23
- Genomics and Rare Diseases 15
Cardiology and Cardiovascular Medicine 38
- Cardiomyopathy and Myosin Studies 27

Co-authors: Bryan Williams Morris J. Brown Simon Thom Nigel G. Laing N. Poulter P S Sever Jane Potter GT McInnes
Journals: Neuromuscular Disorders (24 papers)European Journal of Human Genetics (8 papers)Brain (3 papers)Neurology (3 papers)Muscle & Nerve (3 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Mark R. Davis

115 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary 2004 · 591 citations

Peers

Countries citing papers authored by Mark R. Davis

Since Specialization

Citations

This map shows the geographic impact of Mark R. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Davis more than expected).

Fields of papers citing papers by Mark R. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Davis. The network helps show where Mark R. Davis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark R. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark R. Davis Line = papers co-authored together Mark R. Davis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel SERAC1 Variant Presenting With Adult-Onset Extrapyramidal Dystonia-Parkinsonism Phenotype Neurology Genetics ·Sharanappa Hulleppa, Mark R. Davis, Nigel G. Laing, Gianina Ravenscroft, 一成堀	2023	1
2	Identification of a novel heterozygous DYSF variant in a large family with a dominantly‐inherited dysferlinopathy Neuropathology and Applied Neurobiology ·Emiliana Bezerra Gomes, R. Johnsen, Ulloa Gonzáles, Beata Cholewka, Mark R. Davis, U. Moore, Volker Straub, Rita Barresi, Michela Guglieri, Jean-Francois Lecuyer, Andrew M. Schaefer, Nigel G. Laing, Padmaraj J. Hegde, Gianina Ravenscroft	2022	8
3	A KLHL40 3’ UTR splice-altering variant causes milder NEM8, an under-appreciated disease mechanism Human Molecular Genetics ·Henrique Viana Taveira, G B David, Emilia Servián‐Morilla, Eloy Rivas, Fathimath Faiz, Patricia A. Sullivan, Emily C. Oates, Joshua S. Clayton, Rhonda L. Taylor, Mark R. Davis, Traude H. Beilharz, Nigel G. Laing, Macarena Cabrera‐Serrano, Gianina Ravenscroft	2022	7
4	A TOR1AIP1 variant segregating with an early onset limb girdle myasthenia—Support for the role of LAP1 in NMJ function and disease Neuropathology and Applied Neurobiology ·Edoardo Malfatti, Ayuntamiento de Aras de los Olmos. Valencia. Spain, Sonia Nouioua, Md. Israt Rayhan, Emmanuel Fournier, Robert Carlier, Mike Kearby, Mark R. Davis, Nigel G. Laing, Damien Sternberg, Gianina Ravenscroft	2021	6
5	The Impact of Next-Generation Sequencing on the Diagnosis, Treatment, and Prevention of Hereditary Neuromuscular Disorders Molecular Diagnosis & Therapy ·Sarah J. Beecroft, Phillipa J. Lamont, Samantha Edwards, Hayley Goullée, Mark R. Davis, Nigel G. Laing, Gianina Ravenscroft	2020	7
6	Rapid exome sequencing and adjunct RNA studies confirm the pathogenicity of a novel homozygous ASNS splicing variant in a critically ill neonate Human Mutation ·Lauren Akesson, Adam Bournazos, Andrew Fennell, Emma Krzesinski, Kenneth Tan, Amanda Springer, Katherine Rose, Ilias Goranitis, David Francis, Р М Гареев, Fathimath Faiz, Mark R. Davis, John Christodoulou, Sebastian Lunke, Zornitza Stark, Matthew F. Hunter, Sandra T. Cooper	2020	8
7	A homozygous UBA5 pathogenic variant causes a fatal congenital neuropathy Journal of Medical Genetics ·Macarena Cabrera‐Serrano, David Coote, Dimitar N. Azmanov, Hayley Goullée, Erik Andersen, Catriona McLean, Mark R. Davis, Ryosuke Ishimura, Zornitza Stark, Jean‐Michel Vallat, Masaaki Komatsu, Andrew J. Kornberg, Monique M. Ryan, Nigel G. Laing, Gianina Ravenscroft	2020	19
8	Importance of muscle biopsy to establish pathogenicity of DMD missense and splice variants Neuromuscular Disorders ·Hannah Jones, Samantha J. Bryen, Leigh B. Waddell, Adam Bournazos, Mark R. Davis, Michelle A. Farrar, Catriona McLean, David Mowat, Hugo Sampaio, Ian Woodcock, Monique M. Ryan, Kristi Jones, Sandra T. Cooper	2019	11
9	Study protocol of a multicentre cohort pilot study implementing an expanded preconception carrier-screening programme in metropolitan and regional Western Australia BMJ Open ·Royston Ong, Samantha Edwards, Denise Howting, Benjamin Kamien, 若水川田, Gianina Ravenscroft, Mark R. Davis, Michael Fietz, Nicholas Pachter, John Beilby, Nigel G. Laing	2019	5
10	CUGC for Duchenne muscular dystrophy (DMD) European Journal of Human Genetics ·David Coote, Mark R. Davis, Macarena Cabrera‐Serrano, Merrilee Needham, Nigel G. Laing, Kristen L. Nowak	2018	2
11	AB002. The rare and undiagnosed diseases diagnostic service Annals of Translational Medicine ·Gareth Baynam, Nicholas Pachter, F. Ellis McKenzie, Trombini-Souza Francis, Jennie Slee, Cathy Kiraly‐Borri, Anand Vasudevan, Anne Hunsaker Hawkins, W. G. Whitford, Lyn Schofield, Lorenzo Bianchini, Kym Mina, John Beilby, Mark R. Davis, Tarun Weeramanthri, Hugh Dawkins, Jack Goldblatt	2015	0
12	A germline MTOR mutation in Aboriginal Australian siblings with intellectual disability, dysmorphism, macrocephaly, and small thoraces American Journal of Medical Genetics Part A ·Gareth Baynam, Marek Cernák, Mark R. Davis, Kym Mina, Lyn Schofield, Richard J. N. Allcock, Nigel G. Laing, Matthew Cook, Hugh Dawkins, Jack Goldblatt	2015	31
13	Clinical utility gene card for: Nemaline myopathy – update 2015 European Journal of Human Genetics ·Kristen L. Nowak, Mark R. Davis, Carina Wallgren‐Pettersson, Phillipa J. Lamont, Nigel G. Laing	2015	10
14	A novel mutation expands the genetic and clinical spectrum of MYH7-related myopathies Neuromuscular Disorders ·Nigel F. Clarke, Kimberly Amburgey, James W. Teener, Sandra Camelo‐Piragua, Akanchha Kesari, Jaya Punetha, Leigh B. Waddell, Mark R. Davis, Nigel G. Laing, Nicole Monnier, Kathryn N. North, Eric P. Hoffman, James J. Dowling	2013	29
15	Whole exome sequencing in foetal akinesia expands the genotype–phenotype spectrum of GBE1 glycogen storage disease mutations Neuromuscular Disorders ·Gianina Ravenscroft, Elizabeth M. Thompson, Emily J. Todd, Kyle S. Yau, Nina Kresoje, Padma Sivadorai, Kathryn Friend, Zhiming Wang, Nicholas Manton, Peter Blumbergs, Michael Fietz, Rachael M. Duff, Mark R. Davis, Richard Allcock, Nigel G. Laing	2012	29
16	Early progressive encephalopathy in boys and MECP2 mutations Neurology ·Pongkiat Kankirawatana, Helen Leonard, Carolyn Ellaway, 秦海, Mercedes Olaya-C., GE Xinhui, Leon Dure, Michael J. Friez, Jane B. Lane, Cathy Kiraly‐Borri, Vicki Fabian, Mark R. Davis, J. Brooks Jackson, John Christodoulou, Walter E. Kaufmann, David Ravine, Alan K. Percy	2006	71
17	Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world European Journal of Human Genetics ·Małgorzata Dereniowska, Bjarne Udd, Vesa Juvonen, Peter M. Andersen, Kristina Cederquist, Mark R. Davis, Cinzia Gellera, Wang Houcai, Lars‐Olof Ronnevi, Duy Trinh Nguyễn, Sven Asger Sørensen, Lisbeth Tranebjærg, Lionel Van Maldergem, Masao Watanabe, Markus Weber, Callia Piperides, Marja-Liisa Savontaus	2001	32
18	Genetic studies in a family with autosomal dominant rod and core disease Journal of Leukocyte Biology ·Nigel G. Laing, Francis Mastaglia, Vicki Fabian, Solomiia Ya. Kril, Mark R. Davis, Steve D. Wilton, 张嗣义, John C. Papadimitriou, John F. Valentine, Byron A. Kakulas	1998	1
19	Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model Cancer Immunology Immunotherapy ·Helle Bielefeldt‐Ohmann, David Fitzpatrick, Amanda L. Marzo, Andrew Jarnicki, Robyn Himbeck, Mark R. Davis, Linda S. Manning, B. W. Robinson	1994	48
20	The scientific basis for the immunotherapy of human malignant mesothelioma European Respiratory Review ·Bruce Robinson, Linda S. Manning, O. Oveckova, T.I. Christmas, A W Musk, Mark R. Davis, Helle Bielefeldt‐Ohmann, John W. Upham, M.J. Garlepp	1993	10

About Mark R. Davis

Mark R. Davis is a scholar working on Genetics, Cardiology and Cardiovascular Medicine, Genetics, Cellular and Molecular Neuroscience and Molecular Biology, having authored 119 papers that have together received 4.8k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (29 papers), Cardiomyopathy and Myosin Studies (27 papers), Neurogenetic and Muscular Disorders Research (23 papers), Genetic Neurodegenerative Diseases (16 papers), Genomics and Rare Diseases (15 papers), RNA modifications and cancer (14 papers), Ion channel regulation and function (11 papers) and Occupational and environmental lung diseases (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.1k citations), Genetics (454 citations), Cellular and Molecular Neuroscience (504 citations), Molecular Biology (1.8k citations) and Endocrinology, Diabetes and Metabolism (403 citations). Mark R. Davis has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Bryan Williams, Morris J. Brown, Simon Thom, Nigel G. Laing, N. Poulter, P S Sever, Jane Potter, GT McInnes, Gordon T. McInnes and Neil R Poulter. Their work appears in journals such as Neuromuscular Disorders, European Journal of Human Genetics, Brain, Neurology and Muscle & Nerve.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact